Status:
COMPLETED
GCF IL-17 Levels and Oxidative Status of Smoking and Non-smoking Individuals With Periodontitis
Lead Sponsor:
Ondokuz Mayıs University
Conditions:
Chronic Periodontitis
Smoking, Cigarette
Eligibility:
All Genders
35-60 years
Brief Summary
This study was performed to evaluate the effects of both periodontal treatment and smoking on the gingival crevicular fluid(GCF) levels of interleukin (IL)-17A, IL-17E, Total oxidative stress(TOS) and...
Eligibility Criteria
Inclusion
- individuals aged ˃35 years and having ≥16 teeth diagnosed as chronic periodontitis
- not received any periodontal therapy within the previous 6 months;
- not received antibiotic/anti-inflammatory drug treatment within the previous 6 months.
Exclusion
- receiving medical treatment for cancer, rheumatoid arthritis, diabetes mellitus, cardiovascular disease, or any other systemic disease;
- being pregnant or being in the period of menopause or lactation;
- receiving any drug therapy that might affect the clinical characteristics of periodontitis;
- usage of systemic antimicrobials during the 6 weeks prior to data collection
Key Trial Info
Start Date :
October 10 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 10 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04115176
Start Date
October 10 2017
End Date
July 10 2019
Last Update
October 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Müge Lütfioğlu
Samsun, Atakum, Turkey (Türkiye), 55039